Can scalp electrodes reach deep brain areas to restore arm function after stroke?
NCT ID NCT07792811
First seen Aug 28, 2026 · Last updated Aug 28, 2026
Summary
This study tests a new non-invasive brain stimulation method that targets deep brain structures through the scalp, without surgery, to improve arm and hand function in people who had a stroke at least 12 weeks ago. Participants receive either active stimulation or a sham version, combined with intensive physiotherapy three times a day for a week. Researchers measure changes in arm movement, daily activities, and brain function to see if the treatment is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Non-invasive transcranial Temporal Interference Stimulation (tTIS) targeting the striatum, delivered via scalp electrodes without surgery
- What this could lead to
- If effective, this approach could offer a non-invasive way to boost arm and hand recovery after stroke, potentially improving independence and quality of life for many survivors.
- What could go wrong
- The trial is in early-to-mid stages, and results may not show a clear benefit over sham stimulation. The intensive therapy schedule and individual brain differences could also affect outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
About 84 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Informed Consent signed by the participant 2. Age ≥ 18 years old 3. First ever ischemic stroke with motor impairment 4. Stroke incident ≥ 12 weeks at consent 5. Moderate to severe motor impairment (Fugl-Meyer Assessment (FMA) \>20 and \<58) Exclusion Criteria: 1. Unable to provide informed consent due to cognitive, psychiatric, or medical conditions impairing decision-making capacity 2. Severe neuropsychiatric (e.g., major depression, schizophrenia) or medical disease (e.g., progressive cancer, unstable systemic disease, neurodegenerative disease) 3. Severe cognitive, sensory or musculoskeletal dysfunctions prohibiting to understand instructions or to perform the rehabilitative tasks 4. Contraindications for NIBS or MRI a. Electronic or ferromagnetic medical implants/device, non-MRI compatible metal implant, b. Fully or partially implanted conductive objects i. Passive implants: stents, orthopedic/orthodontic implants, screws, shunts, etc. ii. Active implants: cochlear implants, deep brain stimulation leads and electrodes, fully implanted brain monitoring devices iii. Partially implanted devices: monitoring electrodes (e.g., stereoelectroencephalography, electrocortigraphy, etc. iv. Surface-mounted conductive objects: conductive low-impedance structure mounted to the skin that may introduce shortcuts. c. History of seizures d. Medication that significantly interacts with NIBS being benzodiazepines, tricyclic antidepressants and antipsychotics. e. Non-intact skin where electrodes are intended ot be placed 5. Pregnancy 6. Regular use of narcotic drugs or abusive alcohol consumption 7. Integral and bilateral lesion of the striatum 8. Concomittant participation in another clinical trial 9. Active request of not being informed in case of incidental findings
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ischemic stroke with motor impairment are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CRR SUVA
Sion, Valais, 1951, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Effects of transcranial direct current stimulation and pelvic proprioceptive neuromuscular facilitation on trunk control, balance and functional mobility in stroke patients
- Correlation of visual and motor deficits in stroke patients
- Pilot study on the effects induced by an electromyographic-controlled functional electrical stimulator (FitFES) for upper limb rehabilitation in post-stroke patients
- Brazilian version of a behavior change intervention to support healthy lifestyle adoption after stroke - iVIDAVC: protocol for a pilot randomized study
- Determination of efficacy of sustained motor contraction generated using StimWave peripheral nerve stimulator
- Can a PET tracer reveal hidden brain inflammation?